nimacimab glp-1 news Beyond #obesity": YSM's Jorge Moreno, MD, discussed the potential impact of medications on conditions like #heart disease, #diabetes, kidney disease, and sleep apnea at a recent town hall hosted by South New study examines GLP-1 drugs
Description
Kaufman, has moved GLP-1 agonists way up on her protocol
Patchett, A
If you suspect you are experiencing side effects from any medication, you can report these through the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk
I think of a patient from Arizona who was already maxed out on a DMARD and a biologic together, yet still having multiple flares a month, exhausted and in pain
These medications have undergone extensive clinical trials to evaluate their efficacy and safety in managing type 2 diabetes and, more recently, their potential for weight loss
